Drug and others products shortage in Brazilian health services in the scenario imposed by COVID-19
DOI:
https://doi.org/10.33448/rsd-v11i5.27928Keywords:
COVID-19; Health Services; Pharmaceutical Services; Surveys and questionnaires.Abstract
Objective: We aimed at investigating and describing the drug and material resources in health shortage in the Brazilian services during the COVID-19 pandemic. Methods: We conducted a cross-sectional study in the format of an online survey with closed questions. Information was sought about the institutional and care profile, pharmaceutical service organization, non-compliance in the stock, or lack of drugs and other health products between April and October 2020. We performed descriptive, univariate, and multivariate statistical analyses, such as Fisher's t-test, chi-square test, and the Multiple Correspondence and Hierarchical Cluster analyses. A p-value below 0.05 and a 95% significance level were considered. Results: 228 Brazilian institutions, most located in the capital cities, with specific beds for COVID-19 and public administration, were included in the study. Grouping by similarity separated the study sample into five heterogeneous clusters. Eighty-four percent of the services indicated a drugs shortage, especially neuromuscular blocking agents (64.9%), hypnotics and sedatives (52.9%), vasoactive drugs (37.3%), and antiinfective agents (30%). Conclusion: In all the clusters, there were reports of a shortage of items considered essential in the management of critically-ill patients, corroborating the perception that this was a significant challenge for pharmaceutical assistance in various Brazilian services during the COVID-19 pandemic.
References
Abdi, H., & Valentin, D. (2007). Multiple Correspondence Analysis. Encyclopedia of Measurement and Statistics.
Acosta, A., Vanegas, E. P., Rovira, J., Godman, B., & Bochenek, T. (2019). Medicine Shortages: Gaps Between Countries and Global Perspectives. Frontiers in Pharmacology, 10, 763. https://doi.org/10.3389/fphar.2019.00763
African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators. (2021). Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): A multicentre, prospective, observational cohort study. Lancet (London, England), 397(10288), 1885–1894. https://doi.org/10.1016/S0140-6736(21)00441-4
Agência Nacional de Vigilância Sanitária. (2021, janeiro 18). Painel mostra dados sobre medicamentos para Covid-19. Agência Nacional de Vigilância Sanitária - Anvisa. https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2020/painel-mostra-dados-sobre-medicamentos-para-covid-19
Aljadeed, R., AlRuthia, Y., Balkhi, B., Sales, I., Alwhaibi, M., Almohammed, O., Alotaibi, A. J., Alrumaih, A. M., & Asiri, Y. (2021). The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia. Healthcare, 9(3), 290. https://doi.org/10.3390/healthcare9030290
AlRuthia, Y. S., AlKofide, H., AlAjmi, R., Balkhi, B., Alghamdi, A., AlNasser, A., Alayed, A., Alshammari, M., Alsuhaibani, D., & Alathbah, A. (2017). Drug shortages in large hospitals in Riyadh: A cross-sectional study. Annals of Saudi Medicine, 37(5), 375–385. https://doi.org/10.5144/0256-4947.2017.375
American Society of Health-System Pharmacists. (2021). Drug Shortages Statistics—ASHP. https://www.ashp.org/Drug-Shortages/Shortage-Resources/Drug-Shortages-Statistics
Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences, 28(2), 799–805. https://doi.org/10.1007/s40199-020-00358-5
Badreldin, H. A., & Atallah, B. (2021). Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies. Research in Social & Administrative Pharmacy, 17(1), 1946–1949. https://doi.org/10.1016/j.sapharm.2020.05.017
Bohand, X., Jordan, D., & Dubois, F. (2021). Managing the risk of shortages and medication errors with curares during the COVID-19 pandemic: A hospital pharmacy experience. European Journal of Hospital Pharmacy, ejhpharm-2020-002605. https://doi.org/10.1136/ejhpharm-2020-002605
Botega, L. de A., Andrade, M. V., Guedes, G. R., Botega, L. de A., Andrade, M. V., & Guedes, G. R. (2020). Perfil dos hospitais gerais do Sistema Único de Saúde. Revista de Saúde Pública, 54. https://doi.org/10.11606/s1518-8787.2020054001982
Cadastro Nacional de Estabelecimentos de Saúde. (2021, abril 10). http://cnes.datasus.gov.br/
Cameron, E. E., & Bushell, M.-J. A. (2021). Analysis of drug shortages across two countries during pre-pandemic and pandemic times. Research in Social and Administrative Pharmacy, 17(9), 1570–1573. https://doi.org/10.1016/j.sapharm.2020.12.001
Carvalho, M. S., & Struchiner, C. J. (1992). Análise de correspondência: Uma aplicação do método à avaliação de serviços de vacinação. Cadernos de Saúde Pública, 8(3), 287–301. https://doi.org/10.1590/S0102-311X1992000300008
Castro, M. C., Kim, S., Barberia, L., Ribeiro, A. F., Gurzenda, S., Ribeiro, K. B., Abbott, E., Blossom, J., Rache, B., & Singer, B. H. (2021). Spatiotemporal pattern of COVID-19 spread in Brazil. Science. https://doi.org/10.1126/science.abh1558
Castro, M. C., Massuda, A., Almeida, G., Menezes-Filho, N. A., Andrade, M. V., Noronha, K. V. M. de S., Rocha, R., Macinko, J., Hone, T., Tasca, R., Giovanella, L., Malik, A. M., Werneck, H., Fachini, L. A., & Atun, R. (2019). Brazil’s unified health system: The first 30 years and prospects for the future. The Lancet, 394(10195), 345–356. https://doi.org/10.1016/S0140-6736(19)31243-7
Chaves, G. C., Moraes, E. L., & Osorio-de-Castro, C. G. S. (2021). Estratégias de produção e aquisição de produtos farmacêuticos em contexto de dependência. Cadernos de Saúde Pública, 37(3), e00036821. https://doi.org/10.1590/0102-311x00036821
Clews, G. (2021, março 27). Manufacturing problems cause 60% of medicines shortages, say European wholesalers. The Pharmaceutical Journal. https://pharmaceutical-journal.com/article/news/manufacturing-problems-cause-60-of-medicines-shortages-say-european-wholesalers
Commissioner, O. of the. (2020, setembro 9). Food and Drug Administration. FDA; FDA. https://www.fda.gov/consumers/consumer-updates/combating-antibiotic-resistance
Cundell, T., Guilfoyle, D., Kreil, T. R., & Sawant, A. (2020). Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic. PDA Journal of Pharmaceutical Science and Technology, 74(4), 468–494. https://doi.org/10.5731/pdajpst.2020.012021
Don Eliseo Lucero-Prisno, I. I. I., Elhadi, Y. A. M., Modber, M. A. A., Musa, M. B., Mohammed, S. E. E., Hassan, K. F., Dafallah, A., Lin, X., Ahmadi, A., Adeyemi, S., Ekpenyong, A., & Adebisi, Y. A. (2020). Drug shortage crisis in Sudan in times of COVID-19. Public Health in Practice, 1, 100060.
European Medicines Agency. (2018, setembro 17). Availability of medicines [Text]. European Medicines Agency. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines
Everitt, B., & Dunn, G. (2001). Applied multivariate data analysis. Arnold ; Oxford University Press.
FenaSaúde. (2021). Covid-19 causa aumento de até de 5.275% nos custos dos planos de saúde com medicamentos de intubação | FenaSaude. https://fenasaude.org.br/noticias/covid-19-causa-aumento-de-ate-de-5-275-nos-custos-dos-planos-de-saude-com-medicamentos-de-intubacao.html
Fernandes, D. R. A., Gadelha, C. A. G., & Maldonado, J. M. S. de V. (2021). Vulnerabilidades das indústrias nacionais de medicamentos e produtos biotecnológicos no contexto da pandemia de COVID-19. Cadernos de Saúde Pública, 37(4), e00254720. https://doi.org/10.1590/0102-311x00254720
Ferrando, C., Suarez-Sipmann, F., Mellado-Artigas, R., Hernández, M., Gea, A., Arruti, E., Aldecoa, C., Martínez-Pallí, G., Martínez-González, M. A., Slutsky, A. S., & Villar, J. (2020). Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Medicine, 1–12. https://doi.org/10.1007/s00134-020-06192-2
Food and Drug Administration, O. of the. (2021, outubro 25). U.S. Food and Drug Administration. FDA; FDA. https://www.fda.gov/home
Fox, E. R., Birt, A., James, K. B., Kokko, H., Salverson, S., Soflin, D. L., & Soflin, D. L. (2009). ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 66(15), 1399–1406. https://doi.org/10.2146/ajhp090026
Greenacre, M., & Hastie, T. (1987). The Geometric Interpretation of Correspondence Analysis. 12.
Hoss, M., & Caten, C. S. ten. (2010). Processo de Validação Interna de um Questionário em uma Survey Research Sobre ISO 9001:2000. Produto & Produção, 11(2), Article 2. https://doi.org/10.22456/1983-8026.7240
IBGE | Biblioteca | Detalhes | L’Analyse des donnees / rediges et publies sous la direction du Professeur J. P. Benzecri. -. (2021, janeiro 18). https://biblioteca.ibge.gov.br/biblioteca-catalogo.html?id=222708&view=detalhes
Jager, J., Putnick, D. L., & Bornstein, M. H. (2017). More than Just Convenient: The Scientific Merits of Homogeneous Convenience Samples. Monographs of the Society for Research in Child Development, 82(2), 13–30. https://doi.org/10.1111/mono.12296
Martinez, E. Z., Aragon, D. C., Nunes, A. A., Martinez, E. Z., Aragon, D. C., & Nunes, A. A. (2020). Long-term forecasts of the COVID-19 epidemic: A dangerous idea. Revista Da Sociedade Brasileira de Medicina Tropical, 53. https://doi.org/10.1590/0037-8682-0481-2020
Melo, A. C., Galato, D., Maniero, H. K., Frade, J. C. Q. P., Palhano, T. J., Silva, W. B. da, & João, W. da S. J. (2017). Pharmacy in Brazil: Progress and Challenges on the Road to Expanding Clinical Practice. Canadian Journal of Hospital Pharmacy, 70(5), Article 5. https://doi.org/10.4212/cjhp.v70i5.1700
Merchan, C., Soliman, J., Ahuja, T., Arnouk, S., Keeley, K., Tracy, J., Guerra, G., DaCosta, K., Papadopoulos, J., & Dabestani, A. (2020). COVID-19 pandemic preparedness: A practical guide from an operational pharmacy perspective. American Journal of Health-System Pharmacy: AJHP. https://doi.org/10.1093/ajhp/zxaa212
Miljković, N., Godman, B., Kovačević, M., Polidori, P., Tzimis, L., Hoppe-Tichy, T., Saar, M., Antofie, I., Horvath, L., De Rijdt, T., Vida, R. G., Kkolou, E., Preece, D., Tubić, B., Peppard, J., Martinez, A., Yubero, C. G., Haddad, R., Rajinac, D., … Miljković, B. (2020). Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications. Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.00357
Ministério da Saúde. (2018). Assistência Farmacêutica no SUS: 20 anos de políticas e propostas para desenvolvimento e qualificação: Relatório com análise e recomendações de gestores, especialistas e representantes da sociedade civil organizada [recurso eletrônico] (p. 127).
Nascimento, A. do, Almeida, R. M. V. R., Castilho, S. R. de, & Infantosi, A. F. C. (2013). Análise de correspondência múltipla na avaliação de serviços de farmácia hospitalar no Brasil. Cadernos de Saúde Pública, 29(6), 1161–1172. https://doi.org/10.1590/S0102-311X2013000600013
Oliveira, Ely Francina Tannuri; Grácio, Maria Claudia Cabrini. (2022). Análise a respeito do tamanho de amostras aleatórias simples: Uma aplicação na área de Ciência da Informação. https://brapci.inf.br/index.php/res/v/6591
Omer, S., Pan, M., Ali, S., Shukar, S., Fang, Y., & Yang, C. (2021). Perceptions of pharmacists towards drug shortages in the healthcare system of Pakistan and its impact on patient care: Findings from a cross-sectional survey. BMJ Open, 11(12), e050196. https://doi.org/10.1136/bmjopen-2021-050196
Palomar-Fernández, C., & Álvarez-Díaz, A. (2020). Hospital Pharmacy Service: Facing the logistics of medicines procurement. Farmacia Hospitalaria: Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria, 44(7), 17–20. https://doi.org/10.7399/fh.11489
Passos, M. M. B. dos, Castoldi, V. de M., & Soler, O. (2021). O papel do farmacêutico na pandemia de COVID-19: Revisão integrativa. Research, Society and Development, 10(6), Article 6. https://doi.org/10.33448/rsd-v10i6.15809
Paumgartten, F. J. R., & Oliveira, A. C. A. X. de. (2020). Off label, compassionate and irrational use of medicines in Covid-19 pandemic, health consequences and ethical issues. Ciência & Saúde Coletiva, 25(9), 3413–3419. https://doi.org/10.1590/1413-81232020259.16792020
Pauwels, K., Huys, I., Casteels, M., & Simoens, S. (2014). Drug shortages in European countries: A trade-off between market attractiveness and cost containment? BMC Health Services Research, 14(1), 438. https://doi.org/10.1186/1472-6963-14-438
Pauwels, K., Simoens, S., Casteels, M., & Huys, I. (2015). Insights into European Drug Shortages: A Survey of Hospital Pharmacists. PLOS ONE, 10(3), e0119322. https://doi.org/10.1371/journal.pone.0119322
Pulk, R. A., Leber, M., Tran, L., Ammar, M., Amin, N., Miller, L., & Yazdi, M. (2020). Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management. Am J Health Syst Pharm, 1874–1884.
Reis, A. M. M., & Perini, E. (2008). Desabastecimento de medicamentos: Determinantes, conseqüências e gerenciamento. Ciência & Saúde Coletiva, 13(suppl), 603–610. https://doi.org/10.1590/S1413-81232008000700009
Rosa, M. B., Reis, A. M. M., & Perini, E. (2016). Drug shortage: A public health problem. Cadernos de Saúde Pública, 32(10). https://doi.org/10.1590/0102-311X00086916
Schweitzer, S. O. (2013). How the US Food and Drug Administration Can Solve the Prescription Drug Shortage Problem. American Journal of Public Health, 103(5), e10–e14. https://doi.org/10.2105/AJPH.2013.301239
Secretaria de Governo. (2021). Financiamento na Saúde. Secretaria de Governo. https://www.gov.br/secretariadegoverno/pt-br/portalfederativo/agenda-do-prefeito-brasil/guia-prefeito-200-dias/conteudos-e-orientacoes/saude
Sen-Crowe, B., Sutherland, M., McKenney, M., & Elkbuli, A. (2021). A Closer Look Into Global Hospital Beds Capacity and Resource Shortages During the COVID-19 Pandemic. The Journal of Surgical Research, 260, 56–63. https://doi.org/10.1016/j.jss.2020.11.062
Shortages catalogue | European Medicines Agency. (2021). https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines/shortages-catalogue
Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., Hu, S., Babar, Z.-U.-D., Fang, Y., & Yang, C. (2021). Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in Pharmacology, 12, 1772. https://doi.org/10.3389/fphar.2021.693426
Silva, L. M. C. da, & Araújo, J. L. (2020). Atuação do farmacêutico clínico e comunitário frente a pandemia da COVID-19. Research, Society and Development, 9(7), e684974856–e684974856. https://doi.org/10.33448/rsd-v9i7.4856
Sociedade Brasileira de Farmácia Hospitalar. (2021, abril 21). Levantamento nacional sobre o abastecimento de medicamentos e produtos para a saúde durante o enfrentamento da pandemia pela Covid-19. http://www.sbrafh.org.br/inicial/levantamento-nacional-referente-ao-abastecimento-de-medicamentos-e-produtos-para-a-saude-durante-o-enfrentamento-da-pandemia-pela-covid-19-anexo-do-oficio-no-037-2020-enviado-ao-ministro-da-saude-em/
Ventola, C. L. (2011). The Drug Shortage Crisis in the United States. Pharmacy and Therapeutics, 36(11), 740–757.
Videau, M., Chemali, L., Stucki, C., Saavedra-Mitjans, M., Largana, S., Guerin, A., Bonnabry, P., Delhauteur, B., Hees, T. V., Lebel, D., & Bussières, J.-F. (2019). Drug Shortages in Canada and Selected European Countries: A Cross-Sectional, Institution-Level Comparison. Canadian Journal of Hospital Pharmacy, 72(1), Article 1. https://doi.org/10.4212/cjhp.v72i1.2863
Vogler, S., & Fischer, S. (2020). How to address medicines shortages: Findings from a cross-sectional study of 24 countries. Health Policy (Amsterdam, Netherlands), 124(12), 1287–1296. https://doi.org/10.1016/j.healthpol.2020.09.001
Wallis, N., Gust, C., Porter, E., Gilchrist, N., & Amaral, A. (2020). Implementation of field hospital pharmacy services during the COVID-19 pandemic. American Journal of Health-System Pharmacy: AJHP. https://doi.org/10.1093/ajhp/zxaa211
World Health Organization. (2016). Meeting Report: Technical Definitions of Shortages and Stockouts of Medicines and Vaccines.
World Health Organization. (2021, abril 10). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int
Ying, W., Qian, Y., & Kun, Z. (2020). Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Research in Social & Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2020.04.001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marcelo Rodrigues Martins; Valéria Santos Bezerra; Flávia Neri Meira de Oliveira ; Alice Ramos Oliveira Silva; Elisangela da Costa Lima
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
